X0306 4 2018-06-12 0001624326 PAVmed Inc. PAVM 0001665074 Aklog Lishan ONE GRAND CENTRAL PLACE SUITE 4600 NEW YORK NY 10165 1 1 1 0 Chairman and CEO 0001665114 Pavilion Venture Partners LLC ONE GRAND CENTRAL PLACE SUITE 4600 NEW YORK NY 10165 0 0 1 0 Common Stock 588413 D Common Stock 2018-06-12 4 X 0 1018 A 2303 I By daughter Common Stock 2018-06-12 4 X 0 980 A 2280 I By son Common Stock 4456570 I By Pavilion Venture Partners LLC Common Stock 20000 I By HCFP/AG LLC Series Z Warrants 1.60 2018-04-20 5 G 0 12450 0 D 2018-04-05 2024-04-30 Common Stock 12450 363313 D Subscription Rights (Right to Buy) 1.15 2018-06-12 4 X 0 1018 0 D 2018-05-23 2018-06-12 Units (1 share of Common Stock and 1 Series Z Warrant) 1018 0 I By daughter Series Z Warrants 1.60 2018-06-12 4 X 0 1018 A 2018-04-05 2024-04-30 Common Stock 1018 1018 I By daughter Subscription Rights (Right to Buy) 1.15 2018-06-12 4 X 0 980 0 D 2018-05-23 2018-06-12 Units (1 share of Common Stock and 1 Series Z Warrant) 980 0 I By son Series Z Warrants 1.60 2018-06-12 4 X 0 980 A 2018-04-05 2024-04-30 Common Stock 980 980 I By son Series Z Warrants 1.60 2018-06-26 4 J 0 968019 A 2018-04-05 2024-04-30 Common Stock 2078285 2078285 I By Pavilion Venture Partners LLC Series Z Warrants 1.60 2018-04-05 2024-04-30 Common Stock 10000 10000 I By HCFP/AG LLC The reporting person purchased units from the issuer in the issuer's equity rights offering, each unit consisting of one share of the issuer's common stock and one Series Z Warrant, at a price of $1.15 per unit. Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and has sole voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein. Dr. Aklog is a co-manager of HCFP/AG LLC, and shares joint voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his pecuniary interest therein. Reflects 350,538 Series Z Warrants that previously were held indirectly by Dr. Aklog through HCFP/Capital Partners III LLC, and became held directly by Dr. Aklog on June 26, 2018. The Series Z Warrants were contributed to such entity by its members for no consideration. The contributed Series Z Warrants include 322,673 Series Z Warrants that were previously held indirectly by Dr. Aklog through HCFP/Capital Partners III LLC and became held directly by Dr. Aklog on June 26, 2016. /s/ Dr. Lishan Aklog 2018-07-11 /s/ Dr. Lishan Aklog, as manager of Pavilion Venture Partners LLC 2018-07-11